A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses
Clinical trial NCT03266172 · COMPLETED
Trial details
- NCT number
- NCT03266172
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-27
- Primary completion
- 2018-11-21
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.